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ABSTRACT 
 
Background: The increase of Indonesia’s population life expectancy causes the increase of 
advanced age people. This issued resulted in increasing of degenerative diseases such as 
Hyperplasia Prostate which is the second biggest disease in urology clinic in Indonesia. This study 
aimed to determine the risk factors in the form of age, smoking, alcoholic consumption, physical 
exercise, cholesterol, and diabetes mellitus associated to hyperplasia prostate cases at Prof.Dr. W. 
Z. Johannes, Hospital Kupang. 
Subjects and Method: This was an observational analytic study with case control design. A total 
of the samples were 68 man were collected by random sampling technique. Dependent variable 
was prostate hyperplasia. Independent variables were age, smoking, phisycal exercise, alcohol 
consumption and diabetes mellitus. The data were analyzed by Chi Square.  
Results: This research showed that risk associated the risk factors were age (OR=12.63; 95% CI= 
2.60 to 61.37; p<0.001), smoking (OR=3.52; 95% CI=1.27 to 9.7; p=0.026), physical exercise 
(OR=3.38; 95%CI=1.25 to 9.16; p=0.014), and cholesterol level (OR=3.88; 95%CI= 1.41 to 10.66; 
p=0.007). There was no association on alcohol consumption (OR= 1.33; 95% CI= 0.47 to 3.78; 
p=0.595) and diabetes mellitus (OR=0.88; 95% CI=0.32 to 2.39; p=0.798).   
Conclusion: Increase prevention efforts such as screening prostate specific antigen socialization 
and non-communicable diseases as a prevention in the future. 
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BACKGROUND 
 
Long term planning development of Indo-
nesia Health in 2002 to 2025 with vision of 
Healthy Indonesia 2025 aims to raise 
awareness, ability and willingness to live 
healthily to improve community health 
status as high as possible realized. Success 
of health development is characterized by 
an increased life expectancy from 68.8 in 
2004 to 71.7 in 2011. 
Increasing the life expectancy has 
resulted in elderly population. Increasing 
aging population has led to increase the 
prevalence of degenerative diseases. Most 
of the degenerative diseases or the contagi-
ous disease affects asthma, Parkinson, kid-
ney disorders, prostate hyperplasia osteo-
porosis, chronic obstructive pulmonary di-
sease and rheumatoid arthritis. 
Benigna Prostatic Hyperplasia (BPH) 
or hyperplasia prostatic is an enlarged pro-
state caused by hyperplasia or increase the 
number of cells. The Office of Health Eco-
nomic in England has issued estimates of 
prevalence of symptomatic BPH in England 
and Wales the next few years. The result 
stated that symptomatic BPH patients 
there, amounting around 80,000 patients 
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in 1991, increase to 200,000 patients in the 
year 2031. 
Number of benign prostate patient 
enlargement have not been recorded where 
the benign prostate disease enlargement in-
to second after tract urinate stone disease 
in urology clinic, and generally estimated 
nearly 50% male in Indonesia over 50 years 
up to 65 years suffered BPH. In 2010, Indo-
nesia’s population reached 200 million.  
Based on this amount, number of male 
aged 50 years and above the sum of 5 
million inhabitants, it can be said that 2.5 
million male suffered BPH Indonesia. 
In East Nusa Tenggara, recording of 
the degenerative diseases, especially pros-
tate hyperplasia is still lack. Based on the 
results of the study baseline prevalence of 
hospitalized patients in hospitals Prof. Dr. 
W.Z. Johannes Kupang in 2009 there were 
24 cases of prostatic hyperplasia. In 2010 
cases of prostatic hyperplasia increased to 
38 cases in 2011 dropped to 23 cases. In 
2012 cases of prostatic hyperplasia in-
creased again with the number of 41 cases. 
A total number of prostatic hyperplasia 
patients are 7 cases in January 2013. Based 
on the report the prevalence of outpatient 
prostate hyperplasia number of patients is 
increasing every year. In 2010 the number 
of outpatient prostate hyperplasia as many 
as 874 cases in 2011 increased to 1423 cases 
and in 2012 increased to 1657 cases. Data 
per month outpatient prostate hyperplasia 
in January 2013 amounted to 103 cases, 
and in February there were 88 cases. 
The government has made efforts to 
prevent and detect the degenerative disease 
in the community, such as by encouraging 
an integrated service post and screening 
elderly patients. Such efforts have certain 
constraints, because an integrated service 
post elderly do not run optimally and the 
lack of promotion of screening patients 
resulted in ignorance of the community for 
the early detection by screening, in this case 
for screening prostatic hyperplasia together 
with screening for prostate cancer is the 
Prostate Specific Antigen (PSA). 
Several factors determine cause pros-
tatic hyperplasia that levels of substance 
prostaglandins in the body, levels of tes-
tosterone and the conditions of patients in 
this age, family history, obesity, increaseed 
blood cholesterol, a diet high in animal fat, 
lack of exercise, smoking, alcohol, diabetes 
mellitus, sexual activity, and stress. Based 
on the description above, researchers in-
terested conducting research entitled "Risk 
Factors Associated with Prostate Hyper-
plasia Genesis at Prof. Dr. W.Z. Johannes 
hospital, Kupang." 
This study aimed to determine the 
relationship between age, smoking, alcohol 
consumption, exercise, cholesterol and his-
tory of diabetes mellitus on the incidence of 
prostatic hyperplasia. 
 
SUBJECTS AND METHOD 
 
This was an observational analytic study 
with case control design. This stydy com-
pared between the study group, namely 
people who were sick, with a control group 
of people who were not sick but had chara-
cteristics in common with people who were 
sick or the study group. Comparisons bet-
ween the study group and the control 
group, yielding a value ratio, i.e. the pro-
portion of sick people who had risk factors 
with people who were not sick who had no 
risk factors. That ratio was called the odds 
ratio. 
This research was conducted at Prof. 
Dr. W.Z. Johannes Hospital, Kupang and 
held on January to July 2013 in the out-
patient hospital prostatic hyperplasia from 
January to March 2013, with a large sample 
of cases of 34 patients and a control sample 
of 34 patients were taken using simple ran-
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dom sampling technique and interviews 
using a set of questionnaire and supported 
by medical records.  
The data analysis used univariate and 
bivariate. Univariate analysis was conduct-
ed to elucidate the characteristics of each 
variable. The bivariate analysis was con-
ducted to determine the strength of asso-
ciation between exposure and disease by 
calculating the Odds Ratio using a 2x2 table 
with a confidence level of 95% and a signi-
ficance value of p<0.05. The data were 
analyzed using a computerized system then 
interpreted and presented in table and 
narration. 
 
RESULTS 
 
The univariate analysis included respon-
dents' place of origin, education, occu-
pation, type of respondent control of major 
diseases treated in Poly Surgery. Based on 
the results of the bivariate analysis as age, 
smoking, alcohol consumption, exercise, 
history of cholesterol and diabetes mellitus 
can be seen in Table1. 
Table 1. Distribution of respondents by genesis risk factors against prostate 
hyperplasia at Prof. Dr. Z. W. Johannes hospitals,  Kupang in 2013. 
Factors 
Cases Control 
OR 95% CI p 
n % n % 
Age      
12.63 2.6 to 61.38 <0.001 ≥50 year 32 94.1 19 55.9 
<50 year 2 5.9 15 44.1 
Smoking      
3.52 
 
1.27 to 9.75 0.014 Yes 19 55.9 9 26.5 
No   15 44.1 25 73.5 
Alcohol Consumption     
1.32 
 
0.47 to 3.79 0.595 Yes 11 32.4 9 26.5 
No  23 67.6 25 73.5 
Exercises     
3.378 1.25 to 9.16 0.015 <3 times a week  21 61.8 11 32.4 
≥3 times a week 13 38.2 23 67.6 
History of Cholesterol      
3.87 1.410 to 10.66 0.007 >5.72 mmol/L 24 70.6 13 38.3 
≤5.72 mmol/L 10 29.4 21 61.8 
Diabetes Mellitus     
0.877 0.321 to 2.39 0.798 Yes   11 32.4 12 35.3 
No  23 67.6 22 64.7 
 
According to the Table 1, at the age 
obtained OR=12.632; p<0.001 so it con-
cluded that men aged ≥50 years are at risk 
of experiencing prostate hyperplasia 13 
times more likely than men aged <50 years, 
smoking variable obtained p=0.014; OR= 
3.52, so it can be concluded that men who 
smoke are at risk of experiencing prostate 
hyperplasia 3.5 times greater than men who 
do not smoke.  
Alcohol consumption obtained p= 
0.595, it concluded that alcohol consumpt-
ion does not have a relationship with the 
incidence of prostate hyperplasia. Exercises 
obtained OR=3.378; p=0.015, so it con-
cluded that men who exercised <3 times a 
week had a greater risk of 3 times com-
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pared with men exercising ≥3 times a week. 
Cholesterol history obtained OR= 3.87; 
p=0.007 so it concluded that men who had 
cholesterol >5.72 mmol/L at risk of de-
veloping prostate hyperplasia 4 times more 
likely than men who have a cholesterol 
history ≤5.72 mmol/L. Diabetes mellitus 
obtained p= 0.877, it concluded that dia-
betes mellitus may be related to the in-
cidence of prostate hyperplasia. 
 
DISCUSSION 
 
Increasing age leads to changes in hor-
monal balance, which is between testos-
terone and estrogen. The production of 
testosterone decreases and the conversion 
of testosterone to estrogen in adipose tissue 
in the periphery, with the help of aroma-
terase enzymes, where the properties of 
estrogen will stimulate the receptor's sensi-
tivity prostate cells until the cells increase 
in size (hyperplasia in stroma) that will 
compresse the urethra and impede the flow 
urine. As people age, there will be a decree-
se of testicular function (spermatogenesis) 
which will lead to a progressive decrease of 
androgen secretion and often do not cause 
symptoms or complaints from concerned. 
Someone just feel that there is an enlarged 
prostate when there is disturbance com-
plaint urinate or urinate. 
Based on autopsy figures microscopic 
changes in the prostate can already be 
found at the age of 30-40 years. In men 
aged 50 years and the figure of about 50% 
and at the age of 80 years about 80%. 
The results showed that the age-
related prostate hyperplasia, where men 
aged ≥50 years had a higher risk 13 times 
more likely than men aged <50 years. Most 
respondents prostatic hyperplasia belong to 
the age group at risk (≥50 years) of a total 
of 32 respondents (94%) of the total 40 
respondents case. 
This study conducted by Meissari 
(2008) states that the age associated to 
benign prostatic p<0.001. This study also 
consistent to research conducted by Pawen-
nari (2006) that age ≥50 years the inci-
dence of prostatic hyperplasia associated 
with p<0.001. 
Smoking Association on Prostate 
Hyperplasia in 2013 
Male smokers have greater risk of 61% to 
prostate problems than who did not. Not 
only in difficulty urinating and erectile dys-
function, had smoker also threatened with 
death because of the potential growth of 
tumors in the prostate. 
There are possibilities make smokers 
have a higher risk of prostate enlargement. 
The factors may include carcinogens in 
cigarette smoke and also hormone. Re-
search by Stacey Kenfield found an asso-
ciation between smoking and testosterone 
increasing. This hormone stimulates the 
prostate enlargement. Enlarged prostate, 
occurs when cells of the prostate mutate 
and begin to grow out of control.  These 
cells may spread from the prostate metasta-
tis to other parts of the body, especially the 
bones and lymph nodes. Nicotine in ci-
garettes causes angiogenesis of formation 
of new blood vessels, and it may provide 
food for tumor to grow, including the pros-
tate. 
The result showed that smoking habit 
associated to prostate hyperplasia and men 
who smoke have an increased risk 3.519 
times greater than men who do not smoke. 
The fact discovered when the research was 
19 cases (67.9%) had the habit of smoking. 
Based on the interview, majority of the 
respondents had smoked for more than five 
years and can be smoked ≥12 cigarettes per 
day rod. 
The results are consistent with re-
search conducted by Haryoko (2010) which 
showed that smoking relates to prostate hy-
Indonesian Journal of Medicine (2016), 1(1): 50-57 
https://doi.org/10.26911/theijmed.2016.01.01.07 
54  e-ISSN: 2549-0265 (online) 
perplasia with p=0.023. This study also 
consistent with research conducted by 
Pawennari (2006) which showed no re-
lation between smoking and prostate hy-
perplasia with p=0.035 with the possibility 
of prostatic hyperplasia in men smoke 
amounted to 3.64 times greater than men 
who do not smoke. 
Association of Alcohol Consumption 
on Prostate Hyperplasia in 2013 
Consumption alcohol too much is bad ha-
bit. Among them, makes the head dizzy and 
vomiting, and fatigue. Long-term effects 
may increase the risk of various disease in-
cluding breast cancer, oral cancer, heart 
disease, stroke, prostate, and chronic liver 
disease. Research shows that alcohol con-
sumption in the high level would damage 
the mental health, weaken memory, and 
lower fertility. 
Bivariate analysis showed men have a 
habit of alcohol consumption does not have 
the risk of getting prostate hyperplasia is 
greater than men who did not have history 
of obesity (OR=1.32; 95% CI=0.799 to 3.9 
86). The lack of association between alcohol 
consumption habits and prostate hyper-
plasia because of the respondents did not 
consume alcohol (71%). The number of res-
pondents who did not consume alcohol in 
the case group and the control is almost the 
same, where in 23 respondents (68%), pa-
tients with prostatic hyperplasia not con-
sume alcohol while in patients with pros-
tatic hyperplasia are not 25 respondents 
(73.5%) who did not consume alcohol. 
Based on Amali (2010) shows that the 
habit of alcohol consumption was not 
associated with the prostate hyperplasia 
with p=0.126. The study also supports re-
search Crystals et al., (2008) states that the 
roles of alcohol consumption in the en-
largement is not clear yet, where the con-
sumption of alcohol on a regular according 
to the standard can be lower the risk of 
prostate hyperplasia symptoms become 
33%. Safe standard to consuming alcohol 
according to 2-3 units for women and 3-4 
units for men per day (but not every day). 
One unit of alcohol is equivalent to 300 ml 
beer, or one small glass of wine. Alcohol, 
especially red wine has resveratrol, antioxi-
dants, bioflavonoids and polyphenols have 
the function dilate the arteries and reduce 
inflammation. 
This study is not consistent with re-
search conducted by Gong (2009), which 
men who drink more than 50 grams of 
alcohol (equivalent of 50 grams of 4 glasses 
of beer or four glasses of wine) at risk of 
developing prostate cancer. In prostate pro-
blems, excessive alcohol can neutralize zinc 
(zinc) and vitamin B6, which both these 
substances essential for maintaining pros-
tate health, so that it will occur in the pros-
tate if any shortfall Gangguan both sub-
stances. 
Association the exercises on prostate 
hyperplasia  
Increasing the degenerative diseases such 
as heart attack, hypertension, diabetes, 
cholesterol, making many people know that 
one reason is the lack of activity on a 
regular exercise. Exercise has been proven 
to prevent the emergence of diseases, 
because the body’s metabolism is affected 
body mass.    
The international scale studies have 
handed the findings of the benefits of 
exercises for health and disease prevention. 
Studies conducted by Antonelli (2009) 
revealed that regular exercise can protect 
men from prostate cancer. Based on the 
results, it can be concluded were 190 male 
participants who had a biopsy of the pro-
state. The participants were quite active, 
although just walk for a few hours per 
week, turned out to have significantly less 
likely to get prostate cancer. 
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The results showed that there was a 
relationship between exercise habits to 
prostatic hyperplasia. The results showed 
that men who have a habit of exercise <3 
times a week had a greater chance of 3.378 
times suffer from prostate hyperplasia than 
with a sport toxicity ≥3 times a week. The 
respondents who have a habit to do exer-
cises <3 times a week (62%) compared to 
the control respondents (32%). Based on 
the interview, most respondents did not 
participate in exercises due to physical 
conditions that are old, not accustomed to 
exercise since youth and consider doing the 
housework as a physical work that is equi-
valent to the exercises.  
The results are consistent with re-
search by Amalia (2010) which states that a 
health effect on the prostate hyperplasia 
with OR=3.309; p=0.006. The study also 
supports research Bouilet (2009) which 
exercise affects hormonal habit of being 
able to control excess testosterone to sti-
mulate the cancer and the spread of tu-
mors. Exercise can also help lower blood 
glucose levels and lower insulin release 
which causes growth and development 
tumor. 
Associated historical cholesterol on 
prostate hyperplasia in 2013 
Cholesterol is a sterol metabolites con-
taining fats are commonly found in a cell 
membrane and circulated in blood plasma. 
Cholesterol is type of lipid or species that 
are fatty molecules. Cholesterol has func-
tion as an energy source, forming the walls 
of the cells in the body and as forming of 
steroid hormones. High Density Lipoprotein 
(HDL) serves as a cleaner excess of choles-
terol in the vessel wall to transport it back 
to the liver. Low Density Lipoprotein (LDL) 
or bad cholesterol can lead to attachment of 
cholesterol in the blood vessel walls. 
The results showed that there is a re-
lationship between histories of cholesterol 
on prostatic hyperplasia. The results show-
ed that men who had cholesterol >5.72 
mmol/L has a chance to 3.877 times greater 
than that suffered prostate hyperplasia 
≤5,72 cholesterol mmol / L. The respon-
dents who have a history of cholesterol 24 
respondents (71%) compared to the control 
group 13 respondents (23.2%). 
According to Hogstedt Hammarsten 
(2004) states that the history of the 
cholesterol effect on prostate hyperplasia 
with p = 0.005. The study supported by the 
research by Denti et al., (2006) says that 
the cholesterol effect on prostate hyper-
plasia, when cholesterol levels of patients 
changed after treatment with finasteride 
medicine to prevent prostate hyperplasia. 
Cholesterol is the material synthesis of 
pregnolone the precursor DHEA (dehidro-
epian-androsteron) to produce testoste-
rone, but if excessive will continue in the 
disruption of the prostate (Vitahealth, 
2004). 
Associated Diabetes Mellitus on 
prostate hyperplasia 
Diabetes mellitus is a disease characterized 
by elevated blood glucose levels (hypergly-
cemia) continuous and varied, especially af-
ter a meal or a state of chronic hyperglyce-
mia accompanied by a variety of metabolic 
disorders due to hormonal disturbances, 
which cause a variety of chronic compli-
cations in the eyes, kidneys, and blood ves-
sels, with lesions in the basal membrane in 
the examination with an electron micros-
cope. 
All types of diabetes mellitus have 
similar symptoms and complications at 
advanced levels. Long-term complications 
include cardiovascular disease, chronic 
renal failure (the main cause of dialysis), 
retinal damage which can lead to blindness, 
and nerve damage that can cause impo-
tence and gangrene with risk of ampu-
tation. More serious complications are more 
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common when poor control of blood sugar 
levels. 
Sarma et al., (2007) stated that com-
pared to people without diabetes, men with 
diabetes are more likely to develop pan-
creatic cancer and prostate. Whereas in 
diabetic women had more cases of breast 
cancer, leukemia, or cervical cancer. 
The results showed no association 
between diabetes and the incidence of 
prostate hyperplasia. There is a disconnect-
ion because most respondents did not 
suffer from diabetes mellitus (66%). The 
number of respondents who did not consu-
me alcohol in the case group and the 
control is almost the same, where as many 
as 23 respondents (68%) patients with pro-
static hyperplasia without diabetes mellitus 
whereas in patients with prostatic hyper-
plasia are not 22 respondents (64.7%) who 
did not suffer from diabetes mellitus. 
The results are consistent with re-
search conducted by Amalia (2010) which 
showed that no significant relationship 
between diabetes and prostate hyperplasia. 
In addition, research is also consistent with 
research conducted by Sarma et al., (2009) 
which states that no significant association 
with prostate hyperplasia conducted in 
white men and black in the United States. 
Sarma indicates the presence of diabetes 
may be less related to prostate growth and 
more related to the dynamic component 
functions of the lower urinary tract. A 
maximum flow rate is smaller due to in-
fections of diabetes mellitus in patients 
with prostatic hyperplasia with diabetes 
compared to patients with benign prostatic 
diabetes suffer. 
This study is not consistent with re-
search Vikram et al., (2009) which states 
that there is a relationship between diabet-
es mellitus and prostate hyperplasia after 
conducting experiments in mice given a 
high-fat diet. The mice experienced a pro-
liferation in prostate cells and have an 
enlarged prostate, and after being given 
pioglitazone (a drug to restore insulin levels 
to normal) causes an increase in insulin 
sensitivity thus lowering insulin levels and 
prostate weight. 
Socialization screening the specific 
prostate antigen and keep records of non-
communicable diseases that can be used as 
a reference for future prevention. People 
were expected to avoid or reduce unhealthy 
lifestyle such as smoking and alcohol con-
sumption, exercising and controlling blood 
cholesterol levels. In addition to routine 
medical examination and raise awareness 
by doing screening. For other researchers 
are expected to carry out further research 
on prostate hyperplasia such as analyzing 
influence or investigate other variables that 
have not been investigated in this study. 
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